Amneal Pharmaceuticals (AMRX) Selling, General & Administrative (2017 - 2026)
Amneal Pharmaceuticals (AMRX) Selling, General & Administrative (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.69 Bn | 5.56 Bn | 334.51 Mn | 148.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 148.72 Mn |
| Mar 31, 2026 | 138.86 Mn |
| Dec 31, 2025 | 146.46 Mn |
| Sep 30, 2025 | 137.82 Mn |
| Jun 30, 2025 | 124.27 Mn |
| Mar 31, 2025 | 118.29 Mn |
| Dec 31, 2024 | 128.69 Mn |
| Sep 30, 2024 | 118.69 Mn |
| Jun 30, 2024 | 116.46 Mn |
| Mar 31, 2024 | 112.60 Mn |
| Dec 31, 2023 | 109.00 Mn |
| Sep 30, 2023 | 113.01 Mn |
| Jun 30, 2023 | 105.57 Mn |
| Mar 31, 2023 | 102.10 Mn |
| Dec 31, 2022 | 102.16 Mn |
| Sep 30, 2022 | 100.07 Mn |
| Jun 30, 2022 | 98.81 Mn |
| Mar 31, 2022 | 98.67 Mn |
| Dec 31, 2021 | 97.22 Mn |
| Sep 30, 2021 | 91.40 Mn |